This clinical trial is evaluating an investigational vaccine designed to prevent chlamydia infections, a common sexually transmitted infection that often goes undetected due to lack of symptoms. The study aims to determine the safety, immune response, and effectiveness of the vaccine in adults aged 18 to 29 by administering three different dose levels of the investigational vaccine and comparing the results with a placebo. The study is blinded meaning participants will not know which study group they are in during their participation to avoid bias. Each participant will receive 3 doses of a vaccine for this study which will be given at Day 1, Month 2 and Month 6.
If eligible, participants will be on study for at least 18 months. There will be up to 16 visits to the clinic, not including the 2 visits before vaccination, and up to 5 phone calls during the time.
Each participant will receive 3 doses for this study, given at Day 1, Month 2, and Month 6.
If eligible, participants will be on study for at least 18 months. There will be up to 16 visits to the clinic, not including the 2 visits before vaccination, and up to 5 phone calls during the time. Each participant will receive 3 doses of a vaccine for this study which will be given at Day 1, Month 2 and Month 6.
You will be paid $3,500 for your participation.
